Anti-KDM5A monoclonal antibody

Pre-made anti-KDM5A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to KDM5A/KDM5A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T28052-Ab-1/ GM-Tg-hg-T28052-Ab-2Anti-Human KDM5A monoclonal antibodyHuman
GM-Tg-rg-T28052-Ab-1/ GM-Tg-rg-T28052-Ab-2Anti-Rat KDM5A monoclonal antibodyRat
GM-Tg-mg-T28052-Ab-1/ GM-Tg-mg-T28052-Ab-2Anti-Mouse KDM5A monoclonal antibodyMouse
GM-Tg-cynog-T28052-Ab-1/ GM-Tg-cynog-T28052-Ab-2Anti-Cynomolgus/ Rhesus macaque KDM5A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T28052-Ab-1/ GM-Tg-felg-T28052-Ab-2Anti-Feline KDM5A monoclonal antibodyFeline
GM-Tg-cang-T28052-Ab-1/ GM-Tg-cang-T28052-Ab-2Anti-Canine KDM5A monoclonal antibodyCanine
GM-Tg-bovg-T28052-Ab-1/ GM-Tg-bovg-T28052-Ab-2Anti-Bovine KDM5A monoclonal antibodyBovine
GM-Tg-equg-T28052-Ab-1/ GM-Tg-equg-T28052-Ab-2Anti-Equine KDM5A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T28052-Ab-1/ GM-Tg-hg-T28052-Ab-2; GM-Tg-rg-T28052-Ab-1/ GM-Tg-rg-T28052-Ab-2;
GM-Tg-mg-T28052-Ab-1/ GM-Tg-mg-T28052-Ab-2; GM-Tg-cynog-T28052-Ab-1/ GM-Tg-cynog-T28052-Ab-2;
GM-Tg-felg-T28052-Ab-1/ GM-Tg-felg-T28052-Ab-2; GM-Tg-cang-T28052-Ab-1/ GM-Tg-cang-T28052-Ab-2;
GM-Tg-bovg-T28052-Ab-1/ GM-Tg-bovg-T28052-Ab-2; GM-Tg-equg-T28052-Ab-1/ GM-Tg-equg-T28052-Ab-2
Products NameAnti-KDM5A monoclonal antibody
Formatmab
Target NameKDM5A
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-KDM5A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T28052-Ag-1Recombinant multi-species KDM5A/ RBBP-2/ RBBP2 protein
    ORF Viral VectorpGMAD000038human KDM5A Adenovirus plasmid
    ORF Viral VectorvGMAD000038human KDM5A Adenovirus particle


    Target information

    Target IDGM-T28052
    Target NameKDM5A
    Gene ID5927,214899,312678,721599,477727,101087846,507962,100056935
    Gene Symbol and SynonymsJarid1a,KDM5A,RBBP-2,RBBP2,RBP2
    Uniprot AccessionP29375
    Uniprot Entry NameKDM5A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000073614
    Target ClassificationN/A

    The target: KDM5A, gene name: KDM5A, also named as RBBP-2, RBBP2, RBP2. This gene encodes a member of the Jumonji, AT-rich interactive domain 1 (JARID1) histone demethylase protein family. The encoded protein plays a role in gene regulation through the histone code by specifically demethylating lysine 4 of histone H3. The encoded protein interacts with many other proteins, including retinoblastoma protein, and is implicated in the transcriptional regulation of Hox genes and cytokines. This gene may play a role in tumor progression. [provided by RefSeq, Aug 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.